• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • OWLS/FLS
You are here: Home / Abstracts / Effect of laparoscopic liver resection on hepatic functional reserve: A study of patients with hepatocellular carcinoma with hepatitis C treated with DAA following hepatocellular carcinoma resection

Effect of laparoscopic liver resection on hepatic functional reserve: A study of patients with hepatocellular carcinoma with hepatitis C treated with DAA following hepatocellular carcinoma resection

Mitsuo Miyazawa, MD, FACS1, Masayasu Aikawa, MD2, Katsuya Okada, MD2, Yukihiro Watanabe, MD2, Kojun Okamoto, MD2. 1Teikyo University Mizonokuchi Hospital, 2Saitama Medical University International Medical Center

Backgroud and Aim: Direct acting antivirals (DAAs), oral drugs for hepatitis C, became available for use from September 2014 in Japan, making hepatitis C a curable disease. We evaluated laparoscopic liver resection (LLR) as treatment before DAA administration based on the short-term results of patients with HCC with hepatitis C who had undergone laparoscopic HCC resection, followed by the administration of DAA at our hospita

Method: At our hospital, 206 patients underwent LLR between April 2008 and March 2016, and 144 had HCC. Of these patients, we studied 90 with a diagnosis of hepatitis C virus-related HCC (DAA given to 15 patients; 7 men, 8 women; 14 with genotype 1b, 1 with 2a; IFN ineligible or not given in 5, relapse after pretreatment in 7, non-response to pretreatment in 3; 11 with hepatic damage level A, 4 with level B, 0 with level C). In order to examine the role of LLR in multidisciplinary therapy (including the administration of DAA) for patients with HCC with hepatitis C, we studied 15 patients receiving DAA focusing on the clinical course before administration, LLR perioperative course, and the clinical course after the administration of DAA.

Results: The surgical procedures in 15 patients receiving DAA were laparoscopic partial hepatectomy in 13 and lateral segmentectomy in 2. Blood loss was 52.5 (0-208) mL. The operative time was 207 (127-390) minutes. The duration of postoperative hospitalization was 7.6 (3-13) days. One patient had a postoperative complication (bile leakage, which resolved with conservative treatment). There was no change in the level of liver damage in any of the patients one month after surgery. The administration of DAA was completed in 15 patients. At present, these 15 patients continue to have sustained virological response (SVR). One patient, to date, has developed recurrence.

Conclusion and discussion: We administered DAA to 15 patients with HCC with hepatitis C following LLR. All 15 completed the treatment with DAA and continue to have SVR at present. In this era of DAA, LLR is considered to be a treatment that can achieve switching to DAA therapy while preserving hepatic functional reserve as a multidisciplinary treatment approach for HCC with hepatitis C.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 77432

Program Number: P457

Presentation Session: Poster (Non CME)

Presentation Type: Poster

18

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on Bluesky (Opens in new window) Bluesky

Related


sages_adbutler_leaderboard

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2025 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals